| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 98,576 | 100,446 | 98,693 | 121,948 | | Cost of Revenue | 49,638 | 52,229 | 54,589 | 62,275 | | | Gross Profit | 48,938 | 48,217 | 44,104 | 59,673 | | | Operating Expenses | | Research Development | 11,844 | 12,432 | 12,406 | 11,648 | | Selling General and Administrative | 31,493 | 32,184 | 32,281 | 32,383 | | Non Recurring | 1,003 | (204) | 1,411 | 4,377 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,598 | 3,805 | (1,994) | 11,265 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 72 | (64) | (167) | (749) | | Earnings Before Interest And Taxes | 4,670 | 3,741 | (2,161) | 10,516 | | Interest Expense | 6,481 | 4,878 | 5,992 | 3,843 | | Income Before Tax | (1,811) | (1,137) | (8,153) | 6,673 | | Income Tax Expense | (2,165) | 5,543 | (6,525) | 3,822 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 354 | (6,680) | (1,628) | 2,851 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 354 | (6,680) | (1,628) | 2,851 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $354 | ($6,680) | ($1,628) | $2,851 |
|
1.52% Nasdaq 
Income Statement
